Skip to main content
Top
Published in: Abdominal Radiology 2/2016

01-02-2016 | Classics in Abdominal Imaging

The “Nubbin” Sign

Authors: Pavani Thotakura, Raymond B. Dyer

Published in: Abdominal Radiology | Issue 2/2016

Login to get access

Excerpt

A “nubbin” describes something that is small and stunted, like the pencil sharpened to the last usable length as seen in Fig. 1. This term is also used as a metaphor for the imaging appearance of a diminutive lower pole of the kidney in the setting of a duplicated collecting system. The diminutive lower pole may cause diagnostic confusion, as the nubbin may mimic a mass at imaging [1].
Literature
1.
go back to reference Blair D, Rigsby C, Rosenfield AT (1987) The nubbin sign on computed tomography and sonography. Urol Radiol 9:149–151CrossRefPubMed Blair D, Rigsby C, Rosenfield AT (1987) The nubbin sign on computed tomography and sonography. Urol Radiol 9:149–151CrossRefPubMed
2.
go back to reference Lavallee G, Lafortune M, Gilchrist L, et al. (1985) Obstructed duplex kidney in an adult: ultrasonic evaluation. J Clin Ultrasound 13:281–283CrossRefPubMed Lavallee G, Lafortune M, Gilchrist L, et al. (1985) Obstructed duplex kidney in an adult: ultrasonic evaluation. J Clin Ultrasound 13:281–283CrossRefPubMed
3.
go back to reference Curtis JA, Pollack HM (1979) Renal duplication with a diminutive lower pole: the nubbin sign. Radiology 131:327–331CrossRefPubMed Curtis JA, Pollack HM (1979) Renal duplication with a diminutive lower pole: the nubbin sign. Radiology 131:327–331CrossRefPubMed
Metadata
Title
The “Nubbin” Sign
Authors
Pavani Thotakura
Raymond B. Dyer
Publication date
01-02-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0554-1

Other articles of this Issue 2/2016

Abdominal Radiology 2/2016 Go to the issue

Commentary

Commentary

Classics in Abdominal Imaging

The “molar tooth” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine